GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (BOM:539524) » Definitions » E10

Dr. Lal PathLabs (BOM:539524) E10 : ₹36.46 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹11.580. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹36.46 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Dr. Lal PathLabs's average E10 Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-05), Dr. Lal PathLabs's current stock price is ₹2514.60. Dr. Lal PathLabs's E10 for the quarter that ended in Dec. 2024 was ₹36.46. Dr. Lal PathLabs's Shiller PE Ratio of today is 68.97.

During the past 13 years, the highest Shiller PE Ratio of Dr. Lal PathLabs was 98.94. The lowest was 60.76. And the median was 79.06.


Dr. Lal PathLabs E10 Historical Data

The historical data trend for Dr. Lal PathLabs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs E10 Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 33.50

Dr. Lal PathLabs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.24 33.50 34.53 35.67 36.46

Competitive Comparison of Dr. Lal PathLabs's E10

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Shiller PE Ratio falls into.


;
;

Dr. Lal PathLabs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=11.58/158.3229*158.3229
=11.580

Current CPI (Dec. 2024) = 158.3229.

Dr. Lal PathLabs Quarterly Data

per share eps CPI Adj_EPS
201503 3.470 97.163 5.654
201506 3.720 99.841 5.899
201509 0.750 101.753 1.167
201512 7.310 102.901 11.247
201603 4.140 102.518 6.394
201606 4.850 105.961 7.247
201609 6.430 105.961 9.607
201612 3.750 105.196 5.644
201703 3.840 105.196 5.779
201706 5.400 107.109 7.982
201709 6.180 109.021 8.975
201712 4.390 109.404 6.353
201803 4.870 109.786 7.023
201806 6.000 111.317 8.534
201809 6.900 115.142 9.488
201812 5.550 115.142 7.631
201903 5.700 118.202 7.635
201906 7.130 120.880 9.339
201909 9.750 123.175 12.532
201912 6.550 126.235 8.215
202003 3.940 124.705 5.002
202006 3.440 127.000 4.288
202009 10.310 130.118 12.545
202012 11.410 130.889 13.801
202103 10.090 131.771 12.123
202106 15.840 134.084 18.703
202109 11.450 135.847 13.344
202112 6.900 138.161 7.907
202203 7.420 138.822 8.462
202206 6.960 142.347 7.741
202209 8.600 144.661 9.412
202212 6.330 145.763 6.875
202303 6.820 146.865 7.352
202306 9.930 150.280 10.461
202309 13.120 151.492 13.712
202312 9.760 152.924 10.105
202403 10.170 153.035 10.521
202406 12.760 155.789 12.968
202409 15.480 157.882 15.523
202412 11.580 158.323 11.580

Add all the adjusted EPS together and divide 10 will get our e10.


Dr. Lal PathLabs  (BOM:539524) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dr. Lal PathLabs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2514.60/36.46
=68.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Dr. Lal PathLabs was 98.94. The lowest was 60.76. And the median was 79.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dr. Lal PathLabs E10 Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines